NATUS MEDICAL INC. overview

Natus Sensory is pleased to announce the addition of three accomplished executives to its global leadership team, reinforcing the company’s commitment to advancing innovation, customer impact, and sustainable growth in the hearing and balance, and newborn care spaces. Lon Nelson has joined Natus Sensory as Chief Commercial Officer , where he will lead global Sales, Marketing Communications, Service, and Clinical Education. Lon brings extensive commercial leadership experience from the medical...

Natus Sensory, the world leader in hearing and balance diagnostic systems, announces the official US launch of the ICS® Dizcovery VNG today at the American Academy of Audiology's Annual Convention and Expo in New Orleans, LA. An addition to the well-known and respected portfolio of ICS balance-assessment products, the ICS Dizcovery is the first-ever videonystagmography (VNG) solution to offer all-in-one, plug-and-play goggles that work with a unified diagnostic software platform for...

NATUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Natus Medical Incorporated To Contact The Firm PR Newswire NEW YORK, Feb. 27, 2019 NEW YORK , Feb. 27, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Natus Medical Incorporated ("Natus" or the "Company") (NASDAQ: BABY). If you invested in Natus stock or options and would like to discuss your legal rights,...

Gibbs Law Group is investigating claims on behalf of investors of Natus Medical Incorporated (NASDAQ: BABY) involving possible securities law violations. Specifically, our investigation focuses on allegations that Natus Medical and certain of its officers and/or directors may have engaged in unlawful business practices or securities fraud. To speak privately with an attorney regarding this class action lawsuit investigation, click here . On February 6, 2019, GlassHouse Research published a...

Zamansky LLC announces that it is investigating Natus Medical Incorporated (NASDAQ: BABY) (“Natus” or the “Company”) for potential breaches of fiduciary duties concerning its accounting practices, specifically with regard to its allegedly obsolete inventory. If you are a Natus shareholder and still hold your BABY shares, please contact our firm for further information. As recently reported, Natus’ accounting practices have been called into question by a third-party short seller. It has...

Holzer & Holzer, LLC is investigating whether certain statements made by Natus Medical, Inc. (“Natus Medical” or the “Company”) (NASDAQ: BABY) complied with federal securities laws. On February 6, 2019, the price of Natus Medical shares fell significantly following a short seller report accusing the Company of deceptive accounting practices. If you purchased Natus Medical shares and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at...